216 related articles for article (PubMed ID: 26936002)
1. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
Martin EB; Williams A; Richey T; Stuckey A; Heidel RE; Kennel SJ; Wall JS
Sci Rep; 2016 Mar; 6():22695. PubMed ID: 26936002
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
[TBL] [Abstract][Full Text] [Related]
3. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.
Kennel SJ; Stuckey A; McWilliams-Koeppen HP; Richey T; Wall JS
Mol Imaging Biol; 2016 Aug; 18(4):483-9. PubMed ID: 26573301
[TBL] [Abstract][Full Text] [Related]
5. Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.
Wall JS; Williams A; Richey T; Stuckey A; Wooliver C; Christopher Scott J; Donnell R; Martin EB; Kennel SJ
Mol Imaging Biol; 2017 Oct; 19(5):714-722. PubMed ID: 28229334
[TBL] [Abstract][Full Text] [Related]
6. First in Human Evaluation and Dosimetry Calculations for Peptide
Wall JS; Martin EB; Endsley A; Stuckey AC; Williams AD; Powell D; Whittle B; Hall S; Lambeth TR; Julian RR; Stabin M; Lands RH; Kennel SJ
Mol Imaging Biol; 2022 Jun; 24(3):479-488. PubMed ID: 34786667
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
8. Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis.
Wall JS; Kennel SJ; Martin EB
Mol Imaging; 2017 Jan; 16():1536012117708705. PubMed ID: 28654386
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
Kennel SJ; Jackson JW; Stuckey A; Richey T; Foster JS; Wall JS
PLoS One; 2024; 19(4):e0301756. PubMed ID: 38578730
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.
Wall JS; Martin EB; Richey T; Stuckey AC; Macy S; Wooliver C; Williams A; Foster JS; McWilliams-Koeppen P; Uberbacher E; Cheng X; Kennel SJ
Molecules; 2015 Apr; 20(5):7657-82. PubMed ID: 25923515
[TBL] [Abstract][Full Text] [Related]
12. Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.
Martin EB; Kennel SJ; Richey T; Wooliver C; Osborne D; Williams A; Stuckey A; Wall JS
Peptides; 2014 Oct; 60():63-70. PubMed ID: 25102446
[TBL] [Abstract][Full Text] [Related]
13. Discrete binding patterns of two heparin-reactive proteins, basic fibroblast growth factor and peptide p5R, in amyloid-laden and healthy mice.
Martin EB; Donnell R; Richey T; Stuckey A; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2021 May; 552():136-141. PubMed ID: 33744761
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides.
Martin EB; Williams A; Richey T; Wooliver C; Stuckey A; Foster JS; Kennel SJ; Wall JS
J Transl Med; 2017 Dec; 15(1):247. PubMed ID: 29228957
[TBL] [Abstract][Full Text] [Related]
15. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A
Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869
[TBL] [Abstract][Full Text] [Related]
16. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
[TBL] [Abstract][Full Text] [Related]
17. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
[TBL] [Abstract][Full Text] [Related]
18. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
[TBL] [Abstract][Full Text] [Related]
19. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
Nelson SR; Hawkins PN; Richardson S; Lavender JP; Sethi D; Gower PE; Pugh CW; Winearls CG; Oliver DO; Pepys MB
Lancet; 1991 Aug; 338(8763):335-9. PubMed ID: 1677697
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and monitoring of amyloidosis.
Hawkins PN
Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
